Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday following insider buying activity. The stock traded as high as $137.32 and last traded at $129.67, with a volume of 212340 shares trading hands. The stock had previously closed at $132.03.
Specifically, CFO Jon Christian Bates acquired 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 8th. The shares were purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the acquisition, the chief financial officer now owns 4,888 shares of the company’s stock, valued at approximately $399,887.28. The trade was a 25.72 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Analysts Set New Price Targets
Separately, Maxim Group lifted their target price on Nutex Health from $75.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 8th.
Nutex Health Stock Performance
The stock has a market cap of $756.73 million, a PE ratio of -14.58 and a beta of 0.27. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The stock has a fifty day moving average of $67.40 and a 200-day moving average of $44.16.
Nutex Health (NASDAQ:NUTX – Get Free Report) last announced its quarterly earnings data on Monday, March 31st. The company reported $11.12 EPS for the quarter, beating the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The firm had revenue of $81.30 million during the quarter, compared to analysts’ expectations of $81.13 million.
Institutional Trading of Nutex Health
Large investors have recently modified their holdings of the business. State Street Corp acquired a new position in Nutex Health in the 3rd quarter valued at $225,000. Beaird Harris Wealth Management LLC acquired a new position in Nutex Health during the 3rd quarter worth approximately $69,000. Drive Wealth Management LLC purchased a new position in Nutex Health in the 4th quarter valued at about $1,122,000. Baader Bank Aktiengesellschaft bought a new stake in shares of Nutex Health in the fourth quarter worth $206,000. Finally, Legato Capital Management LLC increased its holdings in Nutex Health by 26.8% in the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company’s stock valued at $1,004,000 after buying an additional 6,697 shares during the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.
Nutex Health Company Profile
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
See Also
- Five stocks we like better than Nutex Health
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- The Risks of Owning Bonds
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Earnings Per Share Calculator: How to Calculate EPS
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.